Updated SG-eCTD version 1.1 package for submissions from 1 April 2026
The Therapeutic Products Branch (TPB) would like to update industry that the SG-eCTD version 1.1 package and the accompanying summary of changes from v 1.0 have been published. The package is available for download as a ZIP file.
SG-eCTD version 1.1 will be the official standard for actual eCTD submissions with effect from 1 April 2026. The current SG eCTD v1.0 package will be removed from the HSA website after the test submission period ends on 27 March 2026. Companies planning to submit their application dossiers via eCTD from April onwards should coordinate with their solution providers to ensure that the necessary technical updates are implemented.
TPB is developing a platform for online access to eCTD technical files to enable real-time validation. We will inform industry stakeholders once this enhancement becomes available.
Login to eCTD portal
Please click here for other eCTD resources. Should you need further clarification on test submissions, please contact us at HSA_TP_eCTD@hsa.gov.sg
eCTD (electronic common technical document) is the standard structured format for the electronic transfer of regulatory information related to therapeutic products from industry to health authorities. eCTD submissions minimise the need for using storage media such as CD/DVD ROMs for dossier submissions. It also allows better product life cycle management for both industry and HSA.
HSA will adopt a phased approach for eCTD implementation for therapeutic product submissions based on ICH eCTD specification 3.2.2.
Bookmark this page for the latest updates or subscribe to HSA announcements.
Contact Us
Technical helpdesk for eCTD portal: eCTD_helpdesk@hsa.gov.sg
For general enquiries, please email us at HSA_TP_ectd@hsa.gov.sg